Cochrane entities >

Cochrane Prognosis Methods Group

What's new

Recent developments in the Prognosis Methods Group

  1. Development of a Research Framework for the Prognosis Methods Group: Please take the  time to look at the Research Framework that has been developed for the Prognosis Methods Group and provide feedback via email to Greta Ridley: ridleyresearch@pacific.net.au.
  2. The Methodology Resource Group: This is a Subgroup of the Prognosis Methods Group that was recently funded by the Novia Scotia Health Research Foundation in Canada (www.nshrf.ca). Once up and running, this Subgroup will help to coordinate and facilitate methodological research relevant to prognosis reviews. The Subgroup aims to develop and maintain databases of relevant methodological studies, protocols, and systematic reviews of prognosis; they will also support relevant training initiatives. Stay tuned for updates of projects and activities. If you wish to obtain more information about this Group, please contact Dr Jill Hayden (jill.hayden@dal.ca).
  3. New publications: Riley RD, Sauerbrei W, Altman DG. Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond, Br. J Cancer (2009) In press. Altman DG. Prognostic models: a methodological framework and review of models for breast cancer. Cancer Investgiation (2009) 27; 235-243. Also see "Our Publications".
  4. CRD's Guidance for Undertaking Reviews in Health Care: Please note this publication is now available on the CRD website and includes a section on Prognostic tests (page 147).(http://www.york.ac.uk/inst/crd/systematic_reviews_book.htm)
  5. Abstract of interest: Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer: a systematic review (Sutcliffe P, Hummel S, Simpson E, Young T, Rees A, Wilkinson A, Hamdy F, Clarke N, Staffurth J).
 
.

Search 

 

top of this page contact disclaimer The Cochrane Library The Cochrane Collaboration